PTIPS治疗脾切除术后并发门静脉血栓形成的门静脉高压症患者安全性和效果分析*

doi:10.3969/j.issn.1672-5069.2018.03.014

摘要/Abstract

摘要： 目的探讨经皮经肝肝内门体分流术（PTIPS）治疗脾切除术后并发门静脉血栓形成的门静脉高压症患者的安全性和效果。方法回顾性分析2011年1月~2015年12月在我院接受PTIPS治疗的30例脾切除术后并发门静脉血栓形成的门静脉高压症患者的病历资料,采用经皮经肝穿刺门静脉分支,采用球囊扩张术扩张闭塞的门静脉和肝内门体分流道,在分流道内植入8 mm的金属支架处理,使用320排CT机检查,随访（22.1±3.8）个月。结果在30例接受PTIPS术患者中,27例（90.0%）手术成功,3例（10.0%）患者因术中未能开通门静脉闭塞而终止手术;27例手术成功患者术前门体静脉压力梯度为（21.5±3.4） mmHg,术后下降至（13.0±2.8） mmHg,差异具有统计学意义（t=10.0,P<0.05）;术后CT检查,发现4例（13.3%）患者发生分流道支架闭塞,均及时给予球囊扩张并再次置入支架处理,血管再通,2例（6.7%）患者发生肝性脑病,给予降血氨药物和营养支持等治疗后好转;5例（16.7%）患者死亡,其中3例死于肝功能衰竭,2例死于脑出血。结论采用PTIPS处理脾切除术后并发门静脉血栓形成的门静脉高压症患者疗效较好,创伤小、较安全,未来仍需进一步深入研究其应用适应证和并发症处理等问题。

关键词: 脾切除术, 门静脉血栓, 经皮经肝肝内门体分流术, 疗效

Abstract: Objective To investigate the safety and efficacy of percutaneous transhepatic intrahepatic portosystemic shunt（PTIPS） in management of patients with portal thrombosis after splenectomy. Methods Thirty patients with portal thrombosis after splenectomy were recruited in our hospital between January 2011 and December 2015. All patients received PTIPS,checked-up by CT scan and followed-up for（22.1±3.8） m. Results The success rate of the operation was 90%（27/30）,and 3 patients failed to opening their portal vein occlusion during operation. No serious complications such as surgical related death were found in this series. The portal-systemic pressure gradient decreased from （21.5±3.4） mmHg to （13±2.8） mmHg in the 27 patients with successful operation. During the follow-up period, 4 patients（13.3%） got the shunt stent occlusion,and repatency by balloon dilatation and a new stent placed instead. 2 patients（6.7%） had hepatic encephalopathy within 1 months after the operation,and were improved after appropriate treatment. 5（16.7%） patients died of hepatic failure or cerebral hemorrhage. Conclusion The application of PTIPS in the management of patients with portal thrombosis after splenectomy is effective,and the procedure is feasible and safe. Further study is still needed in the future to get the indications of this operation.

Key words: Splenectomy, Portal thrombus, Percutaneous transhepatic intrahepatic portosystemic shunt, Efficacy

游玉峰, 谭必勇, 何小俊, 胡红耀. PTIPS治疗脾切除术后并发门静脉血栓形成的门静脉高压症患者安全性和效果分析*[J]. 实用肝脏病杂志, 2018, 21(3): 372-375.

You Yufeng, Tan Biyong, He Xiaojun, et al. Safety and efficacy of percutaneous transhepatic intrahepatic portosystemic shunt in management of patients with portal thrombosis after splenectomy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 372-375.

参考文献

[1] 周松. 肝硬化门静脉高压症手术时机与术式选择. 实用肝脏病杂志,2005,8(3):177-179.
[2] Li MX,Zhang XF,Liu ZW,et al.Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int,2013,12(5):512-519.
[3] Chen XD,He FQ,Yang L,et al.Laparoscopic splenectomy with or without devascularization of the stomach for liver cirrhosis and portal hypertension:a systematic review. ANZ J Surg,2013,83(3):122-128.
[4] Nery F,Chevret S,Condat B,et al.Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis:results of a longitudinal study. Hepatology,2015,61(2):660-669.
[5] Boyer TD,Haskal ZJ.The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. J Clin Gastroenterol,2005,41(2):386-400.
[6] Senzolo M,Tibbals J,Cholongitas E,et al.Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther,2006 23(6):767-775.
[7] Chen Y,Ye P,Li Y,et al.Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic,totally occluded,portal vein thrombosis with symptomatic portal hypertension:procedure technique,safety,and clinical applications. Eur Radiol,2015,25(12):3431-3437.
[8] Lahat E,Lim C,Bhangui P,et al.Transjugular intrahepatic portosystemic shunt as a bridge to non-hepatic surgery in cirrhotic patients with severe portal hypertension: a systematic review. Hpb,2017,29:1-7.
[9] Doshi M,Pereira K,Carrion A,et al.Antegrade embolization of spontaneous splenorenal shunt for post & ndash:transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. Hepatology,2016,64(1):314-319.
[10] Yao J,Zuo L,An G,et al.Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension. J Gastrointestin Liver Dis,2015,24(3):301-307.
[11] Garcíapagán JC,Caca K,Bureau C,et al.Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med,2010,153(10):5-13.
[12] Chen RP,Zhu GX,Huang ZM,et al.Prophylactic use of transjugular intrahepatic portosystemic shunt aids in the treatment of refractory ascites:metaregression and trial sequential meta-analysis. J Clin Gastroenterol,2014,48(3):290-299.
[13] Kim SK,Belikoff BG,Guevara CJ,et al.An algorithm for management after transjugular intrahepatic portosystemic shunt placement according to clinical manifestations. Dig Dis Sci,2017,62(2):1-14.
[14] Pereira K,Carrion AF,Salsamendi J,et al.Endovascular management of refractory hepatic encephalopathy complication of transjugular intrahepatic portosystemic shunt(TIPS):Comprehensive review and clinical practice algorithm. Cardiovasc Intervent Radiol,2016,39(2):170-182.
[15] 蔡炜,诸葛宇征. 肝静脉压力梯度与经颈静脉肝内门体分流术. 实用肝脏病杂志,2013,16(3):204-206.
[16] Jr BB,Cura M,Shaw CJ,et al.Transjugular intrahepatic portosystemic shunt creation using a three-dimensional fluoroscopy guidance system in patients with the Budd-Chiari syndrome. Proc (Bayl Univ Med Cent),2015,28(4):484-487.
[17] 陈志娟,司毅,金瑞,等. 经颈静脉肝内门体分流术联合胃左静脉栓塞术治疗肝硬化食管胃底静脉曲张破裂出血初步临床研究. 实用肝脏病杂志,2017,20(2):238-239.
[18] Ketelsen D,Groezinger G,Maurer M,et al.Three-dimensional C-arm CT-guided transjugular intrahepatic portosystemic shunt placement:Feasibility,technical success and procedural time. Eur Radiol,2016,26(12):1-7.
[19] Thornburg B,Desai K,Hickey R,et al.Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis:Technical considerations. Tech Vasc Interv Radiol,2016,19(1):52-60.
[20] Qi X,Yang M,Fan D,et al.Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome:a critical review of literatures. Scand J Gastroenterol,2013,48(7):771-784.
[21] 罗骏阳,李名安,王皓帆,等. 经皮经肝肝内门体分流术治疗脾切除术后并发门静脉血栓形成的门静脉高压症. 中华肝胆外科杂志,2017,23(6):1-7.
[22] Miraglia R,Maruzzelli L,Cortis K,et al.Digital subtraction angiography during transjugular intrahepatic portosystemic shunt creation or revision:data on radiation exposure and image quality obtained using a standard and a low-dose acquisition protocol in a flat-panel detector-based system. Abdom Imaging,2015,40(6):1808-1812.
[23] Riggio O,Angeloni S,Salvatori FM,et al.Incidence,natural history,and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol,2008,103(11):2738.
[24] Leong S,Hong KK,Govender P,et al.Reducing risk of transjugular intrahepatic portosystemic shunt using ultrasound guided single needle pass. World J Gastroenterol,2013,19(22):3528-3530.
[25] 梁新苗,王慧. 经皮肝穿刺肝内门体分流术的临床护理观察. 临床医学工程,2012,19(10):1797-1798.